TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.080
0.00 (0.00%)
At close: May 29, 2026, 4:00 PM EDT
1.100
+0.020 (1.85%)
After-hours: May 29, 2026, 7:46 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $70.58 million as of May 29, 2026. Its market cap has decreased by -6.23% in one year.
Market Cap
70.58M
Enterprise Value
35.06M
1-Year Change
-6.23%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $70.58M, a decrease of -80.34%. That is a compound annual growth rate of -28.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 70.58M | 24.37% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 74.39M |
| Seres Therapeutics | 74.13M |
| Filana Therapeutics | 72.97M |
| Acrivon Therapeutics | 71.48M |
| Alterity Therapeutics | 69.84M |
| Edesa Biotech | 69.72M |
| BeyondSpring | 69.08M |
| iBio, Inc. | 68.67M |